Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP540169.RALjATORsJgUQJBbjrGFtR2qFQGC4RR6dYQzDSHCvCQKs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP540169.RALjATORsJgUQJBbjrGFtR2qFQGC4RR6dYQzDSHCvCQKs130_assertion type Assertion NP540169.RALjATORsJgUQJBbjrGFtR2qFQGC4RR6dYQzDSHCvCQKs130_head.
- NP540169.RALjATORsJgUQJBbjrGFtR2qFQGC4RR6dYQzDSHCvCQKs130_assertion description "[Subjects with the variant genotypes for SNPs in four of the seven genes evaluated had small increases in bladder cancer risk compared to subjects with the homozygous wild-type genotypes: RAD23B IVS5-15A>G (OR, 1.3; 95% CI, 1.1-1.5; P = 0.01), ERCC2 R156R (OR, 1.3; 95% CI, 1.1-1.6; P = 0.006), ERCC1 IVS5+33A>C (OR, 1.2; 95% CI, 1.0-1.5; P = 0.06; P(trend) = 0.04), and ERCC5 M254V (OR, 1.4; 95% CI, 1.0-2.0; P = 0.04).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP540169.RALjATORsJgUQJBbjrGFtR2qFQGC4RR6dYQzDSHCvCQKs130_provenance.
- NP540169.RALjATORsJgUQJBbjrGFtR2qFQGC4RR6dYQzDSHCvCQKs130_assertion evidence source_evidence_literature NP540169.RALjATORsJgUQJBbjrGFtR2qFQGC4RR6dYQzDSHCvCQKs130_provenance.
- NP540169.RALjATORsJgUQJBbjrGFtR2qFQGC4RR6dYQzDSHCvCQKs130_assertion SIO_000772 16537713 NP540169.RALjATORsJgUQJBbjrGFtR2qFQGC4RR6dYQzDSHCvCQKs130_provenance.
- NP540169.RALjATORsJgUQJBbjrGFtR2qFQGC4RR6dYQzDSHCvCQKs130_assertion wasDerivedFrom befree-2016 NP540169.RALjATORsJgUQJBbjrGFtR2qFQGC4RR6dYQzDSHCvCQKs130_provenance.
- NP540169.RALjATORsJgUQJBbjrGFtR2qFQGC4RR6dYQzDSHCvCQKs130_assertion wasGeneratedBy ECO_0000203 NP540169.RALjATORsJgUQJBbjrGFtR2qFQGC4RR6dYQzDSHCvCQKs130_provenance.